A clinical trial to study the effects of two drugs, Amrutadi Kwath and Kaishor Guggul in patients with Vatarakta with special reference to Hyperuricaemia.
Phase 3
- Conditions
- Health Condition 1: M109- Gout, unspecified
- Registration Number
- CTRI/2024/04/065911
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All genders will be included
Age group 18 to 70 years
All patients clinically diagnosed as vatarakta
Hyperuricemic patients
Patient having uric acid level 6.5 to 12 mg per dl
Exclusion Criteria
1) Patients with renal failure
2) Pregnant and lactating mother
3) patients with known case HIV and leprosy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sr. Uric acidTimepoint: 21 days
- Secondary Outcome Measures
Name Time Method Sandhishula <br/ ><br>Sandhigraha <br/ ><br>Sandhitamravarnata <br/ ><br>Sandhisparshasahatva <br/ ><br>Sandhikriyakashtata <br/ ><br>Sandhishotha <br/ ><br>DahaTimepoint: 21 days